IMPETIGO: Addressing Treatment Adelaide A

Total Page:16

File Type:pdf, Size:1020Kb

IMPETIGO: Addressing Treatment Adelaide A A supplement to IMPETIGO: Addressing Treatment Adelaide A. Hebert, MD Challenges and Burden The UTHealth McGovern Medical School-Houston of Disease Houston, Texas Introduction Review of Impetigo Linda F. Impetigo, a very common bacterial Impetigo affects the epidermal skin Stein Gold, MD skin infection, is a moving target. Over layer with either nonbullous or bul- Henry Ford Health the past few decades there has been lous presentation. Approximately 70% System a shift in the associated bacteriology of all impetigo cases present as the Detroit, Michigan and resistance patterns, making the nonbullous form, which largely affects choice of best treatment more difficult preschool and school-aged children without the benefit of culture and sen- (ages 2-6 years), though all ages can sitivity guidance.1 Evidence that Staph- experience this contagious infection. ylococcus aureus (S. aureus) strains and Impetigo is predominantly caused by S. streptococcal species are developing aureus or Streptococcus pyogenes (S. Author Disclosures resistance to typical first-line topical pyogenes), sometimes referred to as Dr. Hebert: treatments is mounting.2-4 Emergence of group A beta-hemolytic streptococcus Research: Cassiopea, Cutanea, Mupirocin resistance has been reported (GABHS).9,10 Risk of infection increases Dermira, Galderma, GlaxoSmithKline, in several recent studies.5 Methicillin- in populations where hygiene is poor, Leo, Medimetrics, Novan, Pfizer, resistant S. aureus (MRSA) is also a or where there is inadequate access to Sienna, Valeant. All monies paid to growing concern in the community set- housing, health care, and other resourc- The UTHealth McGovern Medical School-Houston, Houston, Texas. ting. Oral penicillin and macrolides are es. Primary infection occurs in intact no longer viable treatment options and skin. Secondary infection occurs fol- Honoraria: Amgen, Cassiopea, resistance is emerging against clinda- lowing excoriation of scabies or insect Cutanea, Novan, Pfizer, Valeant mycin, cephalexin, and linezolid, lead- bites, and/or in the presence of comor- Data safety monitoring Boards (with ing to the potential for more expensive bid conditions such as atopic dermati- honoraria): Bausch, GlaxoSmithKline, and intensive therapies.2,6,7 tis (eczema) and diabetes. Nonbullous Sanofi Regeneron While often described as “self limit- impetigo is characterized by the pres- Dr. Stein Gold: ing,” treatment of impetigo is gener- ence of small pustules that form a Advisor: Cutanea ally advised as this disorder is highly yellow-gold crust located around the This supplement is sponsored by contagious, often requiring isolation nose and mouth as well as on extrem- from school, work, or social activities. ities; it is usually not associated with A multitude of blistering skin disorders systemic symptoms such as fever.6,7,9 S. complicate the differential diagnosis aureus has become more prominent as with no good immediate diagnostic the causative agent in the nonbullous This content was prepared by the tests.7 Additional concerns over disease form, though in more tropical locations specialized content division of progression to more serious problems and indigenous peoples S. pyogenes is Frontline Medical Communications, 7,11 publishers of Dermatology News. put primary caregivers on a precarious still of concern. The bullous form is tipping point, balancing the need for exclusively caused by S. aureus, which Copyright © 2019 Frontline Medical a quick and effective treatment with produces toxins that cause larger su- Communications Inc. All rights reserved. No part of this publication good antibiotic stewardship. Current perficial bullae filled with yellow fluid. may be reproduced or transmitted in treatments include a new topical anti- These occur on the trunk and inter- any form, by any means, without prior biotic, ozenoxacin (Xepi), retapamulin triginous skin of extremeties, mostly in written permission of the Publisher. (Altabax), and the old topical treat- diapered regions of children younger Frontline Medical Communications ments such as mupirocin and fusid- than 2 years of age.6,7,9 Inc. will not assume responsibility ic acid (not available in the United Globally, impetigo has been estimated for damages, loss, or claims of States), which are still widely used as to affect over 100 million people at any any kind arising from or related to first-line therapies. This, coupled with a one time and ranks within the top 50 the information contained in this recent study highlighting the need for burden-inducing disease states.3,12 In the publication, including any claims improved proficiency in impetigo rec- United States, approximately 3 million related to the products, drugs, or 13 services mentioned herein. The ognition, warrants a refresher to ensure cases occur annually. Heat, humid- opinions expressed in this supplement diagnosis and empiric treatment of the ity, and prior skin trauma are pre- do not necessarily reflect the views of infection is well understood by those disposing factors, and as such there the Publisher. on the front lines.7,8 can be seasonal variation favoring warmer weather and exposure to insect outside of the United States, vary great- clothing in hot water (60°C/140°F), and bites.3,7 Incidence rates have been not- ly among studies and demonstrate the keeping fingernails short can help miti- ed to vary over the course of several importance of knowing local resistance gate the spread of bacteria.7,9,19 Natural years, and children with atopic derma- patterns.3 Overall resistance rates to the remedies, such as tea tree oil and Manu- titis are at greater risk for infection.3 commonly prescribed topical antibiot- ka honey have been used with anecdot- Placing a dollar value on the overall ics are reportedly as high as 81%.15 As al success, but are not well studied and burden is difficult as costs of treatment resistance is known to increase health may not satisfy daycare requirements.6,7 constitute only a portion of the total costs due to hospitalization and the Access to readily available disinfec- encumbrance. Lesions in either form need for more expensive and intensive tants and over-the-counter (OTC) top- are highly contagious and require that treatment, this is considered a major ical antibiotics may entice individuals the affected individual be kept from threat to public health.6 or families to self treat. Topical antisep- school or work. Families are impacted Proper diagnosis adds to the diffi- tics are not well studied as comparator when parents must care for infected culty of treatment choice, with both agents, and there is little evidence to children, or when cross-contamination family/caregivers and medical person- support routine use for primary ther- results in the need to treat more than 1 nel potentially attributing skin blisters apy over topical antibiotics.6,7,10 While individual.3,6 Though less severe cases to other causes. Nonbullous impetigo certain alcohol-based hand cleansers,* will self resolve after 4 weeks, treat- may be mistaken as atopic dermatitis, hydrogen peroxide, povidone-iodine, ment is recommended to hasten re- contact dermatitis, scabies, herpes sim- and chlorhexidine solutions are not covery time or prevent progression plex, or varicella zoster virus, and not shown to cause resistance and may to more severe disease and spread to be prescribed the appropriate treat- therefore be used concomitantly, there others. Poststreptococcal glomerulo- ment. The bullous form may be misin- is still the need to consider their overall nephritis and rheumatic heart disease terpreted as insect bites, tinea corporis, environmental impact, and the Dutch have become less common with the eczema, contact dermatitis, or a drug College of General Practitioner’s guide- shift toward S. aureus as the causative eruption.7,8,16 A 2015 survey of pedia- lines recommend they be avoided.3,4,10 pathogen, though glomerulonephritis tricians at Johns Hopkins University Bacitracin is available in combination can occur in up to 5% of nonbullous found that only 31.9% were able to cor- with polymixin B and/or neomycin OTC cases in areas where impetigo is highly rectly diagnose bullous impetigo, and in the United States, and while this OTC prevalent.6,7,10 Antibiotic treatment has though most chose mupirocin as first- product appears to have good labora- not been proven to reduce the inci- line therapy for localized infections, tory data to support its effectiveness dence of glomerulonephritis.7,9 31.3% chose bacitracin, which is not against Gram-positive bacteria, it has Despite the pressure to treat impeti- recommended in either form of impeti- not stood the test of clinical applica- go, clinicians may also feel sanctioned go as a first- or second-line treatment.8 bility and is feared to not effectively to limit antibiotic use in the face of While skin swabs may not be help- eradicate bacteria.1,10 Additionally, it is growing microbial resistance.3,6,7 Anton- ful in determining empiric treatment, implicated in severe contact allergic ov et al reported that 31.3% of all S. cultures should be obtained if MRSA reactions in people both with and with- aureus isolates collected from children is suspected, and serologic tests can out preexisting conditions.4 seen in a predominantly outpatient set- help determine poststreptococcal glo- Most recent reviews indicate that ting in New York City were resistant merulonephritis or herpes simplex vi- there is no significant data to rec- to mupirocin, and that prior mupirocin rus (HSV).7,9,10,17 Differentiation between ommend one topical antibiotic over use was strongly correlated.14 McNeil impetigo and herpes gladiatorum is of another, or to recommend oral ther- et al documented that up to 10% of in particular importance with athletes of apy over topical, and there remains vitro S. aureus isolates from healthy, close-contact sports to ensure early variations across countries on thera- community-based children in the Hous- effective treatment and to avoid trans- py standards.3,7 The topical antibiotics ton area displayed resistance to topical mission.17,18 Of note, many of the di- mupirocin, fusidic acid, or retapamu- antibiotics, including MRSA.
Recommended publications
  • Smelly Foot Rash
    CLINICAL Smelly foot rash Paulo Morais Ligia Peralta Keywords: skin diseases, infectious Case study A previously healthy Caucasian girl, 6 years of age, presented with pruritic rash on both heels of 6 months duration. The lesions appeared as multiple depressions 1–2 mm in diameter that progressively increased in size. There was no history of trauma or insect bite. She reported local pain when walking, worse with moisture and wearing sneakers. On examination, multiple small crater- like depressions were present, some Figure 1. Heel of patient coalescing into a larger lesion on both heels (Figure 1). There was an unpleasant ‘cheesy’ protective/occluded footwear for prolonged odour and a moist appearance. Wood lamp periods.1–4 examination and potassium hydroxide testing for fungal hyphae were negative. Answer 2 Question 1 Pitted keratolysis is frequently seen during What is the diagnosis? summer and rainy seasons, particularly in tropical regions, although it occurs Question 2 worldwide.1,3,4 It is caused by Kytococcus What causes this condition? sedentarius, Dermatophilus congolensis, or species of Corynebacterium, Actinomyces or Question 3 Streptomyces.1–4 Under favourable conditions How would you confirm the diagnosis? (ie. hyperhidrosis, prolonged occlusion and increased skin surface pH), these bacteria Question 4 proliferate and produce proteinases that destroy What are the differential diagnoses? the stratum corneum, creating pits. Sulphur containing compounds produced by the bacteria Question 5 cause the characteristic malodor. What is your management strategy? Answer 3 Answer 1 Pitted keratolysis is usually a clinical Based on the typical clinical picture and the negative diagnosis with typical hyperhidrosis, malodor ancillary tests, the diagnosis of pitted keratolysis (PK) (bromhidrosis) and occasionally, tenderness, is likely.
    [Show full text]
  • Chapter 3 Bacterial and Viral Infections
    GBB03 10/4/06 12:20 PM Page 19 Chapter 3 Bacterial and viral infections A mighty creature is the germ gain entry into the skin via minor abrasions, or fis- Though smaller than the pachyderm sures between the toes associated with tinea pedis, His customary dwelling place and leg ulcers provide a portal of entry in many Is deep within the human race cases. A frequent predisposing factor is oedema of His childish pride he often pleases the legs, and cellulitis is a common condition in By giving people strange diseases elderly people, who often suffer from leg oedema Do you, my poppet, feel infirm? of cardiac, venous or lymphatic origin. You probably contain a germ The affected area becomes red, hot and swollen (Ogden Nash, The Germ) (Fig. 3.1), and blister formation and areas of skin necrosis may occur. The patient is pyrexial and feels unwell. Rigors may occur and, in elderly Bacterial infections people, a toxic confusional state. In presumed streptococcal cellulitis, penicillin is Streptococcal infection the treatment of choice, initially given as ben- zylpenicillin intravenously. If the leg is affected, Cellulitis bed rest is an important aspect of treatment. Where Cellulitis is a bacterial infection of subcutaneous there is extensive tissue necrosis, surgical debride- tissues that, in immunologically normal individu- ment may be necessary. als, is usually caused by Streptococcus pyogenes. A particularly severe, deep form of cellulitis, in- ‘Erysipelas’ is a term applied to superficial volving fascia and muscles, is known as ‘necrotiz- streptococcal cellulitis that has a well-demarcated ing fasciitis’. This disorder achieved notoriety a few edge.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Bacterial Skin Infections
    BACTERIAL SKIN INFECTIONS SPEAKER: DR LUIZ ALBERTO BOMJARDIM PÔRTO DERMATOLOGIST BRAZIL MRSA INFECTIONS • Concept: Methicillin- resistant Staphylococcus aureus • Epidemiology: Gradual increase of resistance. • Nosocomial MRSA risk factors: Hospitalization, ICU, invasive procedures, previous antibiotic therapy, health professionals, diabetes mellitus, EV drugs, immunosuppression and chronic diseases. MRSA INFECTIONS • Community MARSA risk factors: Children, EV drugs, indigenous, homosexual men, military, prisoners and athletes. • Microorganisms more virulent by genetic characteristics. MRSA INFECTIONS • Clinic caracteristics: -Abscess, cellulitis, folliculitis, impetigo, infected wounds, external otitis, paronychia and colonization of the skin in cases of atopic dermatitis. - Increased morbidity. • Propedeutics: Culture blood, tissue or secretion. MRSA INFECTIONS • Treatment: - Pathology-specific treatment. - Prefer non-beta-lactam antibiotics, such as: clindamycin, sulfamethoxazole- trimethoprim and tetracyclines. - On suspicion of MARSA infection, start empirical antibiotics and stagger specific antibiotics by culture with antibiograma. MRSA INFECTIONS • Treatment: - Decolonization: systemic antibiotic therapy, topical 2% mupirocin, personal hygiene with antiseptic or antimicrobial solutions (iodine-povidine, chlorhexidine or triclosan). MRSA INFECTIONS • Prevention: - Avoid skin-to-skin contact and share personal belongings / clothing. - Hand washing. - Use of alcohol gels. - Cover wounds. - Isolation contact of MARSA carriers. - Early
    [Show full text]
  • Bacterial Infections and Infectious Dermatologic Emergencies.Pdf
    Learning Objectives Common Bacterial Infections recognition treatment complications Infectious Dermatologic Emergencies Necrotizing Fasciitis Toxic Shock Syndromes Normal Skin Flora Major function is to prevent skin infections Provides ecological competition for pathogens Hydrolyzes the lipids in sebum into free fatty acids which are toxic to many bacteria- linoleic and linolenic acid are more inhibitory of Staph Aureus Antimicrobial Peptides from lamellar bodies, Cathelicidins, and Defensins function to control overgrowth of pathogens Normal Skin Flora Aerobic Cocci Staphylococcus epidermidis Most common coccus on human skin All body sites, especially intertriginous areas Staphylococcus aureus More common in Atopic Dermatitis, Diabetes Mellitus, Hemodialysis, IVDU, Liver Disease, and HIV resident or contaminant? anterior nares- 20-35% perineum- 20% axillae and toe webs- 5-10% Normal Skin Flora Aerobic Coryneform Bacteria Corynebacterium minutissimum- intertriginous sites Erythrasma Anaerobic Coryneform Bacteria Propionibacterium acnes- sebaceous glands, hair follicles Acne vulgaris Gram Negative Bacteria Acinetobacter species- axillae, perineum, antecubital fossae - Requires moisture and maceration which increases pH and CO2 levels Yeast Pityrosporum ovale/Malassezia furfur- sebaceous sites Tinea Versicolor Introduction Strep and Staph cause the majority of skin infections in immunocompetent patients Immunodeficiency and underlying systemic disease result in severe infections which tend to be refractory to
    [Show full text]
  • Red-Brown Patches in the Groin
    DERMATOPATHOLOGY DIAGNOSIS Red-Brown Patches in the Groin Dong Chen, MD, PhD; Tammie C. Ferringer, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis article in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumu- lating multiple credits. A 66-year-old man presented with reddish arciform patchescopy in the inguinal area. THE BEST DIAGNOSIS IS: a. candidiasis b. noterythrasma c. pitted keratolysis d. tinea cruris Doe. tinea versicolor H&E, original magnification ×600. PLEASE TURN TO PAGE 419 FOR THE DIAGNOSIS CUTIS Dr. Chen is from the Department of Pathology and Anatomical Sciences, University of Missouri, Columbia. Dr. Ferringer is from the Departments of Dermatology and Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania. The authors report no conflict of interest. Correspondence: Dong Chen, MD, PhD, Department of Pathology and Anatomical Sciences, University of Missouri, One Hospital Dr, MA204, DC018.00, Columbia, MO 65212 ([email protected]). 416 I CUTIS® WWW.MDEDGE.COM/CUTIS Copyright Cutis 2018. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. DERMATOPATHOLOGY DIAGNOSIS DISCUSSION THE DIAGNOSIS: Erythrasma rythrasma usually involves intertriginous areas surface (Figure 1) compared to dermatophyte hyphae that (eg, axillae, groin, inframammary area). Patients tend to be parallel to the surface.2 E present with well-demarcated, minimally scaly, red- Pitted keratolysis is a superficial bacterial infection brown patches.
    [Show full text]
  • Download Erythasma
    ERYTHASMA What is it? Erythasma is a common skin condition that affects the following areas – the groin, under the arms and between the toes What does it look like? Erythrasma appears as well-defined scaly red, pink or brown patches. The most commonly affected areas are the groin, armpits, between the toes and in other skin folds. It can sometimes become generalized and affect larger areas on the body. The patches can sometimes be itchy or have an odor. What causes it? Erythrasma is an infection of the skin caused by an overgrowth of a bacterium called Corynebacterium minutissimum. It can affect healthy adults, but it more frequently affects older people with obesity, excessive sweating (hyperhidrosis [link]), diabetes mellitus or people who live in tropical climates. Infection is facilitated under conditions of moisture and occlusion. How is it diagnosed? Erythrasma is diagnosed based on the history and physical appearance of the lesions. A special lamp called a Wood’s lamp can be used to help confirm the diagnosis, as erythrasma glows bright pink under the lamp. How is it treated? Erythrasma can be treated with either topical (applied directly to the skin) or oral therapies. For patients with localised disease, a topical antibiotic such as clindamycin or erythromycin can be used. On the hand, it can be difficult to treat extensive areas with creams and so oral antibiotics (clindamycin or erythromycin) may be preferred. It is important to note that recurrence is common. What can be done to prevent it? In order to avoid recurrences, it is important to keep the skin as dry as possible and optimise pre-disposing conditions such as keeping diabetes well-controlled.
    [Show full text]
  • Erythrasma Capitis and Diffuse Hair Loss with Patches and Eczema-A Rare but Underdiagnozed Entity? Rauno J
    Annals of Case Reports Harvima RJ and Harvima IT Ann Case Report 6: 666. Case Report DOI: 10.29011/2574-7754.100666 Erythrasma Capitis and Diffuse Hair Loss with Patches and Eczema-a Rare but Underdiagnozed Entity? Rauno J. Harvima1*, Ilkka T. Harvima2 1Department of Dermatology, University of Eastern Finland, Kuopio University Hospital and Helsinki University Central Hospital, Finland 2Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Finland *Corresponding author: Rauno J. Harvima, Department of Dermatology, Kuopio University Hospital, Puijonlaaksontie 2, FIN- 70210 Kuopio, Finland Citation: Harvima RJ, Harvima IT. (2021) Erythrasma Capitis and Diffuse Hair Loss with Patches and Eczema-a Rare but Underdiagnozed Entity. Ann Case Report 6: 666. DOI: 10.29011/2574-7754.100666 Received Date: 11 May, 2021; Accepted Date: 14 May, 2021; Published Date: 17 May, 2021 Introduction Corynebacterium minutissimum is considered to belong to the normal flora of skin [1]. However, it can cause a skin disease erythrasma, especially in axillar area. Certain corynebacterium species are associated with skin infections [2,3], and pitted keratolysis. There are only a few reports published for animals regarding the association of corynebacterium and alopecia in one Beagle dog [4], and in two horses [5,6]. However, there are no reports in the literature or in Textbooks of Dermatology on the association of corynebacterium with scalp hair loss in humans. Due to only a few Figure 1a: Patient 1, a healthy 16-year-old woman suffering from patients seen in clinical practice, this association is likely rare, and scalp dermatitis and diffuse hair loss for 2 months, back of head.
    [Show full text]
  • Bacterial Skin Infections
    MYTHS AND FACTS: BACTERIAL SKIN INFECTIONS A better understanding of these often-serious infections that are rising in incidence and becoming more resistant to antibiotics is the first step to improved treatment. Ronale Tucker Rhodes, MS 38 BIO SUPPLY TRENDS QUARTERLY | Summer 2016 DURING THE PAST several years, disturbing headlines about can result in methicillin-resistant Staphylococcus aureas flesh-eating bacteria have raised fear among the public, but few (MRSA), which can be a life-threatening infection because think they’ll actually be the next victim. That was certainly true certain antibiotics in the penicillin family cannot treat it. 8 of Cindy Martinez, who, in May 2015, somehow contracted one Streptococcal infection also can cause many types of infections, strain of the dangerous bacteria known to cause necrotizing but it more regularly causes impetigo, which results in a rash fasciitis. A former Marine and mother of two small children, several days after infection with small blisters that burst and Cindy survived but only after her feet and right hand were leave crusty, golden patches on the skin — occurring most amputated to halt the bacteria’s effects. 1 Necrotizing fasciitis is commonly on the face. 5 Both Staphylococcus and Streptococcus rare. According to the Centers for Disease Control and also commonly cause cellulitis, which can occur anywhere on Prevention (CDC), which tracks specific infections in the U.S. the body; however, the most common location is the lower leg. 9 through a special system called Active Bacterial Core surveillance Cellulitis is a painful infection of the deeper layers of the skin (ABCs), there are about 650 to 850 cases of necrotizing fasciitis that appears as an area of redness, warmth and swelling that caused, predominantly, by group A Streptococcal bacteria each gradually spreads.
    [Show full text]
  • Infectious Diseases of the Philippines
    INFECTIOUS DISEASES OF THE PHILIPPINES Stephen Berger, MD Infectious Diseases of the Philippines - 2013 edition Infectious Diseases of the Philippines - 2013 edition Stephen Berger, MD Copyright © 2013 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-582-4 ISBN-10: 1-61755-582-7 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content: Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application.
    [Show full text]
  • COMMON FUNGUS INFECTIONS of the SKIN by I
    255 Postgrad Med J: first published as 10.1136/pgmj.23.259.255 on 1 May 1947. Downloaded from COMMON FUNGUS INFECTIONS OF THE SKIN By I. R. MARRE, M.R.C.S., L.R.C.P. Skin Physician to the Acton, Evelina and Metropolitan Hospitals. The common superficial mycoses of the skin produce a vigorous reaction, frequently going are caused by a number of different organisms, on to pustulation. and I -propose to give a short general descrip- The Achoria are responsible for the produc- tion of the types of fungi usually responsible tion of favus, characterized by the occurrence for these infections, before proceeding to the of yellowish, cup-shaped scutula. It com- question of diagnosis and treatment. monly affects the scalp, but may affect the hair, There are three groups to be considered:- glabrous skin or nails. The usual organism is I. Ringworm fungi. A. Schonleini, but the group is nowadays 2. Monilia. usually placed in the endothrix trichophyta.' The epidermophyta never affect the hair. 3. Other fungi. They are commonly responsible (especially the I. Ringworm fungi. This is a very large E. inguinale) for infection of the crural region by copyright. class, but we need refer only to the following (Tinea cruris or Dhobie Itch), between the types:- toes and in the nails. (a) Microspora. 2. Monilia. These are a group of yeast-like (b) Trichophyta. fungi, of which the usual one is M. albicans. (c) Achoria. Unlike the ringworm fungi, the manifestations (d) Epidermophyta. of which are usually fairly localized, monilia are capable of serious generalized and systemic http://pmj.bmj.com/ The microspora have small spores in mosaic infections.
    [Show full text]
  • Daniel Zelac, MD Scripps Clinic  Conflicts of Interest – None
    Daniel Zelac, MD Scripps Clinic Conflicts of Interest – None Many of the photographs and diagrams contained in this talk can be referenced in Clinical Dermatology, 5th Edition By Thomas P. Habif, MD Please do not reproduce or distribute further (referenced in talk as “Habif 5th”) Atopic Dermatitis Perleche Allergic Dermatitis Lip Licker’s Dermatitis Herpes Impetigo Aphthous Ulcerative Disease Actinic Chelitis Squamous Cell Carcinoma Skinsight.com AKA ( cheilosis, angular stomatitis) noted for fissures and inflammation of the labial commisures. Primary causes – chemical irritant, nutritional deficiencies(B2, Fe, Zinc) Can be associated with Plummer-Vinson syndrome (esophogeal web, iron deficiency anemia, glossitis, cheilitis) TreatmentSecondary –causes – Overlying infection, Candida or Bacterial correction of underlying medical or physical problem Treatment of any secondary bacterial or fungal infection Allergic Contact Dermatitis – Scaling eczematous inflammatory reaction affecting areas in direct contact or neighboring regions to agents typically used in or around the oral cavity EastMaui.com Mango- has within it’s tree sap a compound called ‘Urushiol’ Contact with the sap externally can Principles of Pediatric Dermatology cause the same reaction in people as poison ivy. Toothpastes and Mouthwashes • Flavorings Mints( Spearmint, Peppermint, Menthol, Carvone) Cinnamal (cinnamon) Anethole (star anise) • Antiseptic Propolis • Plaque control Hexylresorcinol • Anti-Inflammatory Azulene • Florides • Preservatives Parabens Dental Floss • Colophony Rosin- from pine and spruce trees (colophonium, colophony, resinterethinae, tall oil, abietic acid, methyl abietate alcohol, abietic alcohol, abietyl alcohol) Dermnet nz.com Lip Licker’s Dermatitis- Herpes Simplex- Candidiasis Inverse Psoriasis Hailey-Hailey Disease Erythrasma (bacterial infection (C. minutissimum)) Tinea Corporis Hidradenitis Suppurativa Tinea Corporis Hidradenitis Suppurativa • Cause - bacterial infection (C.
    [Show full text]